Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX 5 vs 20 Injections for Overactive Bladder Pain
NCT04305743Phase 4Recruiting
- Sponsor
- University of South Florida
- Start
- Oct 2019
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of botulinum toxin type A in overactive bladder (OAB) and Urinary urge incontinence (UUI) (2 arms), sponsored by University of South Florida. Primary endpoint: Pain from procedure at 5 months. Started Oct 2019; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)Urinary urge incontinence (UUI)
Beyond the preview
Go deeper on NCT04305743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04305743.